Form D · Biotechnology

Kite Pharma, Inc.

Santa Monica, CA · CIK 0001510580

Offering snapshot reported May 2, 2014 · SEC filing

Reported sold
$50M
Offering amount: $50M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 25, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 2, 2014Initial$50,000,000No comparison15SEC filing
May 24, 2013Initial$16,420,598No comparison31SEC filing
Dec 14, 2012Initial$250,000No comparison1SEC filing
Mar 9, 2011Initial$12,453,375No comparison40SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-216713

Source: Form D, filed May 2, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Arie S. Belldegrun Director, Executive
Marc Better Executive
David Bonderman Director
Cynthia M. Butitta Executive
Farah Champsi Director
Roy Doumani Director
Aya Jakobovits Director, Executive
Joshua A. Kazam Director
Gloria Lee Executive
Keith Nolop Executive
Ran Nussbaum Director
Jonathan M. Peacock Director
Margo R. Roberts Executive
Steven B. Ruchefsky Director
Rizwana Sproule Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2225 Colorado Avenue
Santa Monica, CA, 90404